COVID-19 and rheumatoid arthritis
- 22 February 2021
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 33 (3) , 255-261
Abstract
Purpose of review: The coronavirus disease 2019 (COVID-19) pandemic has caused significant morbidity and mortality worldwide. Patients with rheumatoid arthritis (RA) face unique challenges during the pandemic, including concerns regarding infection risk, drug shortages, limited access to care, social isolation, and mental health. This review will examine the multifaceted impacts of the COVID-19 pandemic on patients living with RA. Recent findings: In patients with RA, risk factors for severe COVID-19 outcomes include older age and comorbidities, similar to those in the general population. Glucocorticoids, but not other classes of disease-modifying antirheumatic drugs (DMARDs), appear to be associated with a higher risk of severe COVID-19 outcomes. RA patients have been affected by changes in access to care, telemedicine, drug shortages, anxiety, and social isolation, which may contribute to disease flares. Summary: Glucocorticoids, but not other DMARDs, are associated with a higher risk of severe COVID-19 outcomes in RA patients. Further studies are needed to explore the impact of specific DMARDs on COVID-19 outcomes, understand the broader implications of the COVID-19 pandemic on RA disease activity, and optimize the use of telemedicine in RA management.Keywords
This publication has 30 references indexed in Scilit:
- What is the true incidence of COVID-19 in patients with rheumatic diseases?Annals of the Rheumatic Diseases, 2021
- COVID-19 and rheumatology: first steps towards a different future?Annals of the Rheumatic Diseases, 2020
- Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapiesAnnals of the Rheumatic Diseases, 2020
- COVID-19 infection and rheumatoid arthritis: Faraway, so close!Autoimmunity Reviews, 2020
- Mitigating the wider health effects of covid-19 pandemic responseBMJ, 2020
- Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID‐19 PandemicACR Open Rheumatology, 2020
- The Lung in Rheumatoid ArthritisArthritis & Rheumatology, 2018
- Risk of Venous Thromboembolism in Patients With Rheumatoid ArthritisArthritis Care & Research, 2013
- High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2011
- Frequency of infection in patients with rheumatoid arthritis compared with controls: A population‐based studyArthritis & Rheumatism, 2002